News

RadNet (Nasdaq:RDNT) announced an agreement to acquire iCad (Nasdaq:ICAD) in an all-stock transaction for approximately $103 ...
Abbott reported first quarter results that beat the Wall Street analyst consensus on earnings but missed on revenue.
Edwards Lifesciences announced today that it received CE mark approval for its Sapien M3 mitral valve replacement system.
Terumo Neuro (formerly MicroVention) announced today that it received FDA premarket approval (PMA) for its Carotid Stent ...
EBR designed its WiSE system to significantly expand the population of patients who could benefit from CRT. The leadless ...
Imperative Care announced that it intends to fund a trial comparing its Zoom stroke system plus best medical treatment to ...
Phantom Neuro announced today that it raised $19 million in a Series A funding round to support its neural interface technology.
DESKi today announced FDA clearance of HeartFocus, its AI-enabled heart exam software. Bordeaux, France–based DESKi says it only takes a few hours of training for any healthcare professional, ...
Lifeward (Nasdaq:LFWD) announced today that it launched the next-generation ReWalk 7 personal exoskeleton in the United States.
CeriBell (Nasdaq:CBLL) announced today that it received FDA 510(k) clearance for its next-generation Ceribell Clarity algorithm.
Johnson & Johnson (NYSE: JNJ) shares dipped slightly today on first-quarter results that came in ahead of the consensus forecast.
Sequana Medical announced today that CMS recommended that its Alfapump system become eligible for a new incremental payment.